Drug General Information
Drug ID
D02NSF
Former ID
DIB004983
Drug Name
Oxymorphone
Synonyms
Oxymorphone (abuse-resistant, pain); Oxymorphone (abuse-resistant, pain), Pain Therapeutics/ King Pharmaceuticals; Oxymorphone (abuse-resistant, pain), Pain Therapeutics/Pfizer
Drug Type
Small molecular drug
Indication Moderate to severe pain [ICD10:R52, G89] Approved [551871]
Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] Phase 4 [522753], [542100]
Therapeutic Class
Neurology Agents
Company
Pain Therapeutics Inc
Structure
Download
2D MOL

3D MOL

Formula
C17H19NO4
InChIKey
UQCNKQCJZOAFTQ-ISWURRPUSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Opioid receptor Target Info Modulator [542100]
References
Ref 522753ClinicalTrials.gov (NCT00955110) Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin). U.S. National Institutes of Health.
Ref 542100(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7094).
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 542100(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7094).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.